Our Blog

Why Serratiopeptidase Stability Matters

Serratiopeptidase is a proteolytic enzyme widely used in combination with analgesics and anti-inflammatory agents to help reduce inflammation, oedema, and pain. Unlike conventional chemical drugs, enzymes are inherently sensitive to environmental conditions such as temperature, humidity, and storage duration. Over time, their biological activity can gradually decline, potentially affecting the therapeutic performance of the formulation.

To overcome this challenge, pharmaceutical manufacturers often incorporate enzyme overages during formulation. This is a scientifically accepted manufacturing strategy that helps ensure the product delivers the intended enzyme activity throughout its shelf life.

What Are Serratiopeptidase Overages?

An overage refers to adding a quantity of an active ingredient above the label claim during manufacturing. This compensates for the predictable loss of potency that occurs naturally during production, storage, and distribution.

For enzyme-based medicines such as Serratiopeptidase, overages are carefully calculated based on stability studies to ensure that the labelled potency remains available until the product reaches the patient.

Why Are Overages Important?

1. Maintains Enzyme Activity Throughout Shelf Life

Serratiopeptidase is susceptible to gradual degradation over time. Including an appropriate overage helps ensure that the enzyme retains its required activity until the expiry date, maintaining consistent clinical effectiveness.

2. Delivers Reliable Clinical Performance

Healthcare professionals prescribe medicines expecting consistent therapeutic outcomes. Adequate enzyme activity ensures predictable anti-inflammatory and anti-oedema effects throughout the product's life cycle.

3. Protects Against Manufacturing and Storage Variations

Even under WHO-GMP manufacturing standards, minimal potency losses may occur due to processing, packaging, transportation, and storage conditions. Overage acts as a safeguard against these expected variations.

4. Supports Consistent Patient Outcomes

Maintaining enzyme potency helps patients receive the intended therapeutic benefit from every dose, improving treatment reliability and confidence.

Why 65% Overages?

In formulations like ATMOL-SP, a 65% overage of Serratiopeptidase is incorporated to compensate for the expected reduction in enzyme activity over time.

This approach helps:

• Preserve enzymatic activity throughout the product's shelf life.
• Maintain labelled potency until expiry.
• Ensure consistent anti-inflammatory efficacy.
• Deliver dependable clinical performance across different storage conditions.

Rather than indicating a higher therapeutic dose, the overage is designed to ensure that the patient ultimately receives the intended labelled enzyme activity throughout the product's usable life.

The Complete Pain Management Advantage

ATMOL-SP combines:

• Aceclofenac – Effective pain relief and anti-inflammatory action.
• Paracetamol – Reliable analgesic and antipyretic effect.
• Serratiopeptidase – Supports reduction of inflammation and oedema.

In addition, the formulation is designed for rapid disintegration in approximately 3 minutes, allowing quicker tablet dispersion and supporting a faster onset of action.

Combined with the inclusion of 65% Serratiopeptidase overages, the formulation is engineered to provide both rapid availability and sustained enzyme potency throughout its shelf life.

Key Benefits at a Glance

• ✔ 65% Serratiopeptidase overages help maintain enzyme potency during storage.
• ✔ Supports consistent therapeutic efficacy until product expiry.
• ✔ Preserves enzymatic activity for reliable anti-inflammatory performance.
• ✔ Helps ensure predictable clinical outcomes.
• ✔ Rapid tablet disintegration in approximately 3 minutes for faster onset of action.
• ✔ WHO-GMP manufactured with stringent quality standards.

Conclusion

The effectiveness of enzyme-based medicines depends not only on the ingredients they contain but also on maintaining their biological activity over time. By incorporating 65% overages of Serratiopeptidase, formulations like ATMOL-SP are designed to compensate for expected potency loss, helping preserve enzyme activity and deliver consistent therapeutic efficacy throughout the product's shelf life.

This scientific formulation approach, combined with rapid tablet disintegration and a proven analgesic combination, makes ATMOL-SP a dependable option for comprehensive pain and inflammation management.